Notably, the inhibition of PPAR-α activation exacerbated DOX-induced podocytopathy and glomerulopathy in mice kidney and murine podocytes, possibly by reducing autophagy and decreasing FFA oxidisation. Here, PPARA is linked to lipoprotein glomerulopathy.